13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q1 2024. See the latest, Q2 2026 →
Reported value
$604.23B
+7.5% on the quarter before
Positions
517
30 new · 20 sold out
Top 10
29.4%
of the value
Est. gain
+$52.95B
on stocks held all quarter
Est. return
+10.3%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Flutter Entmt Plc~$2.88BNew · 0.0% → 0.5%+14,587,046 shares
- General Electric Co~$2.16BAdded · 0.0% → 0.4%+12,312,648 shares
- Amazon~$2.08BAdded · 0.5% → 0.9%+11,524,463 shares
- Schlumberger Ltd~$2.05BAdded · 0.5% → 0.8%+37,333,485 shares
- Vertex Pharmaceuticals Inc~$1.57BAdded · 1.6% → 1.8%+3,761,414 shares
- Dell Technologies Inc~$835.9MNew · 0.0% → 0.1%+7,325,793 shares
- Shopify Inc~$797.9MAdded · 0.5% → 0.6%+10,340,040 shares
- Eaton Corp Plc~$762.7MAdded · 0.0% → 0.2%+2,439,270 shares
- Walt Disney Company (The)~$744.6MAdded · 0.0% → 0.1%+6,084,993 shares
- Merck & Co Inc~$742.6MAdded · 0.2% → 0.3%+5,627,923 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$3.34BCut · 6.1% → 5.8%−7,931,356 shares
- Broadcom~$2.58BCut · 5.5% → 5.7%−1,948,823 shares
- Te Connectivity Ltd~$2.18BCut · 0.6% → 0.2%−15,043,471 shares
- Eli Lilly~$1.88BCut · 2.8% → 3.2%−2,413,718 shares
- Applied Materials~$1.80BCut · 0.8% → 0.6%−8,715,242 shares
- Pfizer Inc~$1.69BCut · 0.9% → 0.5%−60,732,791 shares
- Salesforce~$1.31BCut · 0.9% → 0.8%−4,354,137 shares
- Linde Plc~$1.29BCut · 0.9% → 0.7%−2,787,922 shares
- Boeing Co~$1.24BCut · 0.8% → 0.3%−6,442,101 shares
- L3harris Technologies Inc~$967.1MCut · 0.6% → 0.4%−4,538,460 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −8.8% · price +11.9% | 5.8% | $34.75B | +$3.69B | ||||||||
| BroadcomCOM · shares −7.0% · price +18.7% | 5.7% | $34.39B | +$5.43B | ||||||||
| Eli LillyCOM · shares −9.0% · price +33.5% | 3.2% | $19.09B | +$4.79B | ||||||||
| MetaCL A · shares +0.6% · price +37.2% | 3.1% | $18.60B | +$5.01B | ||||||||
| Home Depot IncCOM · shares −1.9% · price +10.7% | 2.4% | $14.45B | +$1.40B | ||||||||
| Unitedhealth Group IncCOM · shares −1.9% · price −6.0% | 2.3% | $14.01B | −$899.7M | ||||||||
| Canadian Nat Res LtdCOM · shares +0.5% · price +16.4% | 1.8% | $11.01B | +$1.55B | ||||||||
| Vertex Pharmaceuticals IncCOM · shares +17% · price +2.7% | 1.8% | $10.69B | +$242.4M | ||||||||
| Caterpillar IncCOM · shares −3.0% · price +23.9% | 1.7% | $10.32B | +$1.99B | ||||||||
| Philip Morris Intl IncCOM · shares +1.5% · price −2.6% | 1.7% | $10.19B | −$269.5M | ||||||||
| NvidiaCOM · shares −5.0% · price +82.5% | 1.6% | $9.88B | +$4.47B | ||||||||
| Thermo Fisher Scientific IncCOM · shares +10% · price +9.5% | 1.3% | $7.84B | +$618.3M | ||||||||
| NetflixCOM · shares −1.1% · price +24.7% | 1.2% | $7.05B | +$1.40B | ||||||||
| AlphabetCAP STK CL C · shares +2.2% · price +8.0% | 1.2% | $6.96B | +$507.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares +0.4% · price +17.8% | 1.1% | $6.89B | +$1.03B | ||||||||
| TeslaCOM · shares −4.7% · price −29.3% | 1.1% | $6.87B | −$2.84B | ||||||||
| Gilead Sciences IncCOM · shares +1.4% · price −9.6% | 1.0% | $6.19B | −$646.9M | ||||||||
| TSMCSPONSORED ADS · shares +1.7% · price +30.8% | 0.95% | $5.72B | +$1.33B | ||||||||
| Booking Holdings IncCOM · shares −11% · price +2.3% | 0.93% | $5.59B | +$124.3M | ||||||||
| AlphabetCAP STK CL A · shares +1.7% · price +8.0% | 0.88% | $5.34B | +$391.3M | ||||||||
| Asml Holding N VN Y REGISTRY SHS · shares −1.5% · price +28.2% | 0.88% | $5.34B | +$1.18B | ||||||||
| AmazonCOM · shares +65% · price +18.7% | 0.88% | $5.30B | +$507.2M | ||||||||
| Visa Inc.COM CL A · shares +5.4% · price +7.2% | 0.87% | $5.26B | +$335.2M | ||||||||
| Comcast Corp NewCL A · shares +7.4% · price −1.1% | 0.83% | $5.02B | −$54.0M | ||||||||
| Schlumberger LtdCOM STK · shares +72% · price +5.3% | 0.81% | $4.88B | +$143.0M | ||||||||
| Total · 517 positions | 100% | $604.23B | +$52.95B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 483 stocks held throughout, up $52.95B (+10.3%).
- Broadcom+$5.43B+19%
- Meta+$5.01B+37%
- Eli Lilly+$4.79B+33%
- Nvidia+$4.47B+82%
- Microsoft+$3.69B+12%
- Alnylam Pharmaceuticals Inc−$536.7M−22%
- Gilead Sciences Inc−$646.9M−10%
- Boeing Co−$730.2M−26%
- Unitedhealth Group Inc−$899.7M−6%
- Tesla−$2.84B−29%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |